ONCY - Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021 Results - Earnings Call Transcript
Oncolytics Biotech Inc. (ONCY) Q2 2021 Results Earnings Conference Call August 06, 2021, 08:00 AM ET Company Participants Jon Patton - Director, IR and Communication Matt Coffey - President and CEO Tom Heineman - Global Head, Clinical Development and Operations Andrew de Guttadauro - Global Head, Business Development Kirk Look - CFO Conference Call Participants John Newman - Canaccord Patrick Trucchio - H.C. Wainwright Presentation Operator Good morning. And welcome to Oncolytics Biotech’s Second Quarter 2021 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the end of this call. Please be advised that this call is being recorded at the Company’s request. I would now like to turn the call over to Jon Patton, Director of Investor Relations and Communication. Please go ahead. Jon Patton Thank you, operator. And good afternoon, everyone. Earlier today, Oncolytics issued a press release providing financial results
For further details see:
Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2021 Results - Earnings Call Transcript